These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 10573186

  • 41. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL, Bartlett JL, Ananthan S, Bilsky EJ.
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [Abstract] [Full Text] [Related]

  • 42. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
    Barber A, Bartoszyk GD, Bender HM, Gottschlich R, Greiner HE, Harting J, Mauler F, Minck KO, Murray RD, Simon M.
    Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
    [Abstract] [Full Text] [Related]

  • 43. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
    Negri L, Improta G, Lattanzi R, Potenza RL, Luchetti F, Melchiorri P.
    Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
    [Abstract] [Full Text] [Related]

  • 44. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance.
    Lutfy K, Doan P, Nguyen M, Weber E.
    Eur J Pharmacol; 1999 Nov 12; 384(1):1-5. PubMed ID: 10611412
    [Abstract] [Full Text] [Related]

  • 45. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
    Bileviciute-Ljungar I, Spetea M, Guo Y, Schütz J, Windisch P, Schmidhammer H.
    J Pharmacol Exp Ther; 2006 Apr 12; 317(1):220-7. PubMed ID: 16339394
    [Abstract] [Full Text] [Related]

  • 46. Novel selective κ agonists SLL-039 and SLL-1206 produce potent antinociception with fewer sedation and aversion.
    Wei YY, Ma Y, Yao SY, Kong LH, Liu X, Chai JR, Chen J, Li W, Wang YJ, Shao LM, Liu JG.
    Acta Pharmacol Sin; 2022 Jun 12; 43(6):1372-1382. PubMed ID: 34493813
    [Abstract] [Full Text] [Related]

  • 47. Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats.
    Stoller DC, Sim-Selley LJ, Smith FL.
    Brain Res; 2007 Apr 20; 1142():28-36. PubMed ID: 17300766
    [Abstract] [Full Text] [Related]

  • 48. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
    Tham SM, Angus JA, Tudor EM, Wright CE.
    Br J Pharmacol; 2005 Mar 20; 144(6):875-84. PubMed ID: 15778704
    [Abstract] [Full Text] [Related]

  • 49. [Differentiation of antinociceptive effects of mu, delta and kappa agonists using heat, chemical and mechanical nociception].
    Murakawa K, Noma K, Matsuda M, Maeda S, Tashiro C, Izumi R.
    Masui; 1996 Aug 20; 45(8):937-42. PubMed ID: 8818088
    [Abstract] [Full Text] [Related]

  • 50. TRK-820, a selective kappa opioid receptor agonist, could effectively ameliorate L-DOPA-induced dyskinesia symptoms in a rat model of Parkinson's disease.
    Ikeda K, Yoshikawa S, Kurokawa T, Yuzawa N, Nakao K, Mochizuki H.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):42-8. PubMed ID: 19686730
    [Abstract] [Full Text] [Related]

  • 51. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
    Yang PP, Yeh GC, Yeh TK, Xi J, Loh HH, Law PY, Tao PL.
    Pharmacol Res; 2016 Sep 12; 111():867-876. PubMed ID: 27496654
    [Abstract] [Full Text] [Related]

  • 52. Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.
    Mathews JL, Peng X, Xiong W, Zhang A, Negus SS, Neumeyer JL, Bidlack JM.
    J Pharmacol Exp Ther; 2005 Nov 12; 315(2):821-7. PubMed ID: 16076937
    [Abstract] [Full Text] [Related]

  • 53. Involvement of spinal kappa opioid receptors in the antagonistic effect of dynorphins on morphine antinociception.
    Song ZH, Takemori AE.
    Life Sci; 1991 Nov 12; 48(15):1447-53. PubMed ID: 1672725
    [Abstract] [Full Text] [Related]

  • 54. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE, Sun HS, Darpolar M, Leitermann RJ, Kampine JP, Tseng LF.
    J Pharmacol Exp Ther; 2003 Dec 12; 307(3):1135-41. PubMed ID: 14557378
    [Abstract] [Full Text] [Related]

  • 55. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
    Cichewicz DL, Martin ZL, Smith FL, Welch SP.
    J Pharmacol Exp Ther; 1999 May 12; 289(2):859-67. PubMed ID: 10215664
    [Abstract] [Full Text] [Related]

  • 56. Effects of a newly synthesized kappa-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats.
    Mori T, Nomura M, Nagase H, Narita M, Suzuki T.
    Psychopharmacology (Berl); 2002 Apr 12; 161(1):17-22. PubMed ID: 11967626
    [Abstract] [Full Text] [Related]

  • 57. The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats.
    Zamarripa CA, Pareek T, Schrock HM, Prisinzano TE, Blough BE, Sufka KJ, Freeman KB.
    Psychopharmacology (Berl); 2021 Dec 12; 238(12):3463-3476. PubMed ID: 34430992
    [Abstract] [Full Text] [Related]

  • 58. Dextromethorphan differentially affects opioid antinociception in rats.
    Chen SL, Huang EY, Chow LH, Tao PL.
    Br J Pharmacol; 2005 Feb 12; 144(3):400-4. PubMed ID: 15655510
    [Abstract] [Full Text] [Related]

  • 59. Cromakalim differentially enhances antinociception induced by agonists of alpha(2)adrenoceptors, gamma-aminobutyric acid(B), mu and kappa opioid receptors.
    Ocaña M, Barrios M, Baeyens JM.
    J Pharmacol Exp Ther; 1996 Mar 12; 276(3):1136-42. PubMed ID: 8786544
    [Abstract] [Full Text] [Related]

  • 60. Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence.
    Neumeyer JL, Bidlack JM, Zong R, Bakthavachalam V, Gao P, Cohen DJ, Negus SS, Mello NK.
    J Med Chem; 2000 Jan 13; 43(1):114-22. PubMed ID: 10633042
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.